Trump administration's response to the drug crisis hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, March 7, 2019.
| Main Author: | United States. Congress. House. Committee on Oversight and Reform, |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Washington :
U.S. Government Publishing Office,
2019-
|
| Physical Description: |
1 online resource (volumes) |
| Subjects: | |
| Online Access: |
https://purl.fdlp.gov/GPO/gpo122680 |
| Item Description: |
Part 1 lacks numeric designation but constitutes the first part of the work. Part 2 has title: The Trump administration's response to the drug crisis. "March 7, 2019"--Pt. 1. "May 9, 2019"--Pt. 2. "Serial no. 116-07"--Pt. 1. "Serial no. 116-21"--Pt. 2. Access ID (govinfo, pt. 1): CHRG-116hhrg36619. Access ID (govinfo, pt. 2): CHRG-116hhrg36437. GPO Cataloging Record Distribution Program (CRDP). Hearing witnesses (pt. 1): James W. Carroll, Jr., Office of National Drug Control Policy; Triana McNeil, Acting Director, Strategic Issues, Government Accountability Office; Mike McDaniel, Director, Houston High Intensity Drug Trafficking Area. Hearing witnesses (pt. 2): The Honorable James W. Carroll Jr., Director, Office of National Drug Control Policy; Ms. Triana McNeil, Acting Director, Homeland Security and Justice, Government Accountability Office; Ms. Karyl Thomas Rattay, M.D., M.S., Director, Delaware Division of Public Health; Mr. Wayne Ivey, Sheriff, Brevard County, Florida. Date of hearing (pt. 1): 2019-03-07. Date of hearing (pt. 2): 2019-05-09. |
|---|---|
| Physical Description: |
1 online resource (volumes) |